Next Generation Sequencers Market grows with rapid adoption of technology by researchers and academicians

Next generation sequencers are used inthe sequencing technologies which massively parallelize the DNA sequencing process rather than being limited to single or few fragments of DNA. The next generation sequencing (NGS) technology enables rapid sequencing and produce thousands and millions of sequences in single run with the use of next generation sequencers. Such technologies have been rapidly developing owing to continuous demand for high-throughput (next generation) sequencers which tend to lower the cost of DNA sequencing.

The global next generation sequencers market is categorized on the basis of technologies segmented as single-molecule real-time sequencing (SMRT), ion semiconductor sequencing, pyrosequencing, sequencing by synthesis, sequencing by ligation and chain termination. All these technologies are proprietary and protected through intellectual property rights. The NGS technologies have overcome the limitations of capillary electrophoresis -based Sanger Sequencing with respect to throughput, scalability, speed and resolution and therefore highly preferred these days.

Geographically, the global market for next generation sequencers is segmented into four major regions, namely, North America, Europe, Asia-Pacific and rest of the world. The funding from federal government and agencies in the U.S. and Canada makes the North American region, the largest market for next generation sequencers. The European and Asian market are also expected to grow substantially due to encouragement by government to use NGS technology.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=574

The major driving factorsfor the global next generation sequencers market are the low cost and speed for DNA sequencing. Other market drivers include the rapid adoption of technology by researchers and academicians, utility for varied application in sequencing and its usability as a substitute for microarray technology.Reduction in the research expenditures by government and university are temporarily impeding the market growth, however the scenario is expected to change once the global economy revives. There is a huge opportunity for NGS technology in the field of biological drug discovery, personalized medicine, agricultural & animal research.

Some of the market players in this industry segment are Agilent Technologies, Inc.,Illumina, Inc., BGI (Beijing Genomics Institute), Biomatters, Ltd., Pacific Biosciences, Dnastar, Inc., Oxford Nanorpore Technologies, Ltd., EMC Corporation, Life Technologies Corporation, Genomatix Software GMBH, Partek Incorporated, Macrogen, Inc., OcimumBiosolutions, Ltd., Perkinelmer, Inc., Qiagen N.V., GATC biotech AG and Knome, Inc.

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: